The Biologics Analytical R&D group supports AbbVie’s early-stage biologics pipeline, including monoclonal antibodies, bispecifics and multispecifics, antibody-drug conjugates, antibody-oligonucleotide conjugates, tLNPs, peptides, and other biologic medicines. The group develops analytical methodologies and supports drug substance and drug product process and formulation development for traditional, high-concentration, and complex formulations, partnering across Biologics CMC to deliver high-quality drug products. The Director will lead the Early Phase Analytical Development group at AbbVie’s Lake County (North Chicago headquarters) site. The role is accountable for multiple pipeline projects, scientific and technological development, people management, and implementation of functional strategies. The Director ensures team deliverables meet established timelines and budgets, use allocated resources effectively, and comply with regulatory, quality, and safety requirements. The Director will establish phase-appropriate analytical development strategies for the early-phase pipeline; oversee analytical method development, validation, transfer, and quality control; and ensure appropriate control strategies from candidate screening through Phase 1 and Phase 2 clinical studies. The role leads a team of more than 20 scientists, analytical leads, and people leaders; develops talent and succession plans; drives technology and operational improvements; and manages partnerships across Discovery, Synthetic Molecule CMC, Biologics CMC, CMC RA, PDS&T, Operations, and QA.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree